416-share cashless exercise reported by Mineralys (NASDAQ: MLYS)
Rhea-AI Filing Summary
Mineralys Therapeutics submitted a Form 144 notifying the sale of 416 shares of Common Stock on 04/17/2026 via a broker-assisted cashless exercise of employee stock options. The filing also lists multiple recent open-market dispositions by David Rodman over the prior three months, with individual sales such as 14,058 shares on 04/13/2026 ($373,086.81) and 6,348 shares on 04/15/2026 ($175,585.68).
Positive
- None.
Negative
- None.
Insights
Routine Rule 144 sale notice for option exercise and prior insider sales.
The filing documents a broker-assisted cashless exercise that resulted in the sale of 416 shares on 04/17/2026. A cashless exercise commonly satisfies tax and option exercise obligations by selling a portion of acquired shares through a broker.
The record of multiple recent sales by David Rodman is disclosed as required; the listed transactions show specific share counts and gross proceeds. This Form 144 is an administrative notice of intended sale under Rule 144 and does not by itself change the company’s financial statements or governance.